Human Trials Of Drugs
- All
- News
- Videos
-
Google Ready To Start Human Trials Of Its AI-Designed Drugs
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Indonesia Starts Testing Homegrown Covid Vaccine On Humans
Indonesia began testing a homegrown Covid-19 vaccine on humans Wednesday after getting the green light from the drug regulator as the country faces a rising wave of virus cases.
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
-
"Antisera" With Potential To Treat Covid Gets Nod For Phase-1 Human Trials
The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for COVID-19, ICMR officials said on Tuesday.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
Dr Reddy's Seeks Nod For Phase 3 Trial Of Russian Covid Vaccine In India
Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct phase-3 human clinical trials of the Russian vaccine Sputnik V against COVID-19 in India, sources said.
-
Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the University of Oxford, in the country.
-
Google Ready To Start Human Trials Of Its AI-Designed Drugs
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Indonesia Starts Testing Homegrown Covid Vaccine On Humans
Indonesia began testing a homegrown Covid-19 vaccine on humans Wednesday after getting the green light from the drug regulator as the country faces a rising wave of virus cases.
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
-
"Antisera" With Potential To Treat Covid Gets Nod For Phase-1 Human Trials
The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for COVID-19, ICMR officials said on Tuesday.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
Dr Reddy's Seeks Nod For Phase 3 Trial Of Russian Covid Vaccine In India
Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct phase-3 human clinical trials of the Russian vaccine Sputnik V against COVID-19 in India, sources said.
-
Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the University of Oxford, in the country.
